Pfizer CEO Albert Bourla (Evan Vucci, AP Images)
December 16, 2021 12:31 PM EST
Cell/Gene Tx
Manufacturing

Pfiz­er opens doors at newest gene ther­a­py site in NC as part of $800M push in­to next-gen drugs

Kyle Blankenship

The Covid-19 pan­dem­ic has been an ex­treme­ly prof­itable time for Pfiz­er, and the mas­sive drug­mak­er is us­ing that lever­age to ad­vance its port­fo­lio writ large …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times